Acusphere (ACUS) Stock Price, News & Analysis

Company Overview

Acusphere, Inc. is a pharmaceutical company that developed drug-delivery products using proprietary porous microparticle and microsphere technologies. These technologies were designed to improve the formulation and delivery of active pharmaceutical ingredients in injectable and inhaled medicines.

The company’s best-known product is Imagify, an injectable ultrasound contrast agent containing perflubutane microspheres. Imagify was approved by the U.S. Food and Drug Administration for use in adults with suboptimal echocardiograms, helping physicians enhance the visualization of the heart and improve assessment of cardiac function.

Acusphere’s publicly documented activities have primarily focused on the development and commercialization of pharmaceutical products in the United States. The company’s historical disclosures emphasize research and development, regulatory approval, and licensing or commercialization arrangements related to its drug-delivery platform. More recent reliable information about its operating activities, leadership, and geographic presence is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/28/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:ACUS
• CIK: N/A
• Web: www.acusphere.com
• Phone: (617) 648-8800
• Fax: 978-863-9993
• Employees: 118
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A